A World Without Disease: Can We Get There?
Research!America will host an interactive panel discussion on June 20 titled, A World Without Disease: Can We Get There?, at the BIO International Convention in San Diego, California. During the session, experts from the regulatory, pharmaceutical, and advocacy sectors will discuss the implications of new technologies and the challenges of leveraging limited resources to maximize patient benefit.
Research!America’s session will seek to address the question, “how can we capitalize on insights from the biotechnology industry and facilitate a coordinated effort to eradicate disease?”. To do so, Research!America board member William Hait, M.D., Ph.D., global head at Janssen Research and Development, who spoke at the 2016 BIO International Convention, will be joined by fellow board member Mark McClellan, M.D., Ph.D., MPA, director, Duke-Robert J. Margolis, MD, Center for Health Policy, Duke University; and Donna Cryer, JD, president and CEO of the Global Liver Institute. Luke Timmerman, founder and editor, Timmerman Report, will moderate the panel.
“I hate to say it, but all of us are incubating some awful disease,” Hait said during Research!America’s 2016 National Health Research Forum. “At each step along this journey, there [are] opportunities to develop solutions that will interrupt the disease-causing process.”
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO) and is the largest global event for the biotech industry. It is an opportunity to network with other leading biotech experts and share insights on major trends affecting the industry.
Other sessions at the convention will explore drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy. The event will also feature an Exhibition Hall, showcasing the work of many Research!America alliance members.
To learn more about the BIO International Convention, visit www.convention.bio.org.